Kathleen A. Rickard - 20 Oct 2023 Form 4 Insider Report for Verona Pharma plc (VRNA)

Role
Chief Medical Officer
Signature
/s/ Claire Poll, Attorney-in-fact for Kathleen A. Rickard
Issuer symbol
VRNA
Transactions as of
20 Oct 2023
Net transactions value
$0
Form type
4
Filing time
24 Oct 2023, 16:06:38 UTC
Previous filing
07 Aug 2023
Next filing
03 Nov 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRNA Ordinary Shares Award $0 +200,000 +7% $0.000000 3,072,528 20 Oct 2023 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
F2 Represents an award of Restricted Share Units ("RSUs"), each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer. The RSUs vest over four years, with 50,000 RSUs vesting on November 1, 2024 and the balance vesting in 12 equal quarterly installments thereafter.
F3 Consists of (i) 1,751,792 Ordinary Shares underlying RSUs (which are represented by 218,974 ADSs); and (ii) 1,320,736 Ordinary Shares underlying 165,092 ADSs.